{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:56:09Z","timestamp":1790722569097,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41391-026-01132-5","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T20:11:42Z","timestamp":1783714302000},"page":"885-891","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["No racial disparities in prostate cancer-specific mortality after biochemical recurrence following radical prostatectomy or radiation therapy"],"prefix":"10.1038","volume":"29","author":[{"given":"Carlo","family":"Silvani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Santangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Considine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Niculcea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5415-9901","authenticated-orcid":false,"given":"Akshay","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Nazzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0595-7165","authenticated-orcid":false,"given":"Andrea","family":"Salonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6867-7646","authenticated-orcid":false,"given":"Nicola","family":"Nicolai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Montanari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1298-8231","authenticated-orcid":false,"given":"Firas","family":"Abdollah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"1132_CR1","first-page":"290","volume":"66","author":"CE DeSantis","year":"2016","unstructured":"DeSantis CE, Siegel RL, Sauer AG, Miller KD, Fedewa SA, Alcaraz KI, et al. Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities. CA Cancer J Clin. 2016;66:290\u2013308.","journal-title":"CA Cancer J Clin"},{"key":"1132_CR2","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1001\/jamaoncol.2019.0826","volume":"5","author":"RT Dess","year":"2019","unstructured":"Dess RT, Hartman HE, Mahal BA, Soni PD, Jackson WC, Cooperberg MR, et al. Association of Black Race With Prostate Cancer\u2013Specific and Other-Cause Mortality. JAMA Oncol. 2019;5:975\u201383.","journal-title":"JAMA Oncol"},{"key":"1132_CR3","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1002\/cncr.35386","volume":"130","author":"SA Tinsley","year":"2024","unstructured":"Tinsley SA, Finati M, Stephens A, Chiarelli G, Cirulli GO, Williams E, et al. Race has no impact on prostate cancer\u2013specific mortality, when comparing patients with similar risk of other-cause mortality: An analysis of a population-based cohort. Cancer. 2024;130:3157\u201369.","journal-title":"Cancer"},{"key":"1132_CR4","doi-asserted-by":"publisher","first-page":"e2326546","DOI":"10.1001\/jamanetworkopen.2023.26546","volume":"6","author":"N Sayegh","year":"2023","unstructured":"Sayegh N, Swami U, Jo Y, Gebrael G, Haaland B, Gupta S, et al. Race and Treatment Outcomes in Patients With Metastatic Castration-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG 1216 Phase 3 Trial. JAMA Netw Open. 2023;6:e2326546.","journal-title":"JAMA Netw Open"},{"key":"1132_CR5","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1002\/cncr.34433","volume":"128","author":"JrJW Lillard","year":"2022","unstructured":"Lillard JrJW, Moses KA, Mahal BA, George DJ. Racial disparities in Black men with prostate cancer: A literature review. Cancer. 2022;128:3787\u201395.","journal-title":"Cancer"},{"key":"1132_CR6","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.euf.2016.03.010","volume":"2","author":"DE Spratt","year":"2016","unstructured":"Spratt DE, Chen Y-W, Mahal BA, Osborne JR, Zhao SG, Morgan TM, et al. Individual Patient Data Analysis of Randomized Clinical Trials: Impact of Black Race on Castration-resistant Prostate Cancer Outcomes. Eur Urol Focus. 2016;2:532\u20139.","journal-title":"Eur Urol Focus"},{"key":"1132_CR7","doi-asserted-by":"publisher","first-page":"e2332900","DOI":"10.1001\/jamanetworkopen.2023.32900","volume":"6","author":"UG Falagario","year":"2023","unstructured":"Falagario UG, Abbadi A, Remmers S, Bj\u00f6rnebo L, Bogdanovic D, Martini A, et al. Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy. JAMA Netw Open. 2023;6:e2332900.","journal-title":"JAMA Netw Open"},{"key":"1132_CR8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.eururo.2014.09.017","volume":"67","author":"BH Lee","year":"2015","unstructured":"Lee BH, Kibel AS, Ciezki JP, Klein EA, Reddy CA, Yu C, et al. Are Biochemical Recurrence Outcomes Similar After Radical Prostatectomy and Radiation Therapy? Analysis of Prostate Cancer\u2013Specific Mortality by Nomogram-predicted Risks of Biochemical Recurrence. Eur Urol. 2015;67:204\u20139.","journal-title":"Eur Urol"},{"key":"1132_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/cncr.23139","volume":"112","author":"MC Abramowitz","year":"2008","unstructured":"Abramowitz MC, Li T, Buyyounouski MK, Ross E, Uzzo RG, Pollack A, et al. The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer. Cancer. 2008;112:55\u201360.","journal-title":"Cancer"},{"key":"1132_CR10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.eururo.2013.08.022","volume":"66","author":"MC Mir","year":"2014","unstructured":"Mir MC, Li J, Klink JC, Kattan MW, Klein EA, Stephenson AJ. Optimal Definition of Biochemical Recurrence After Radical Prostatectomy Depends on Pathologic Risk Factors: Identifying Candidates for Early Salvage Therapy. Eur Urol. 2014;66:204\u201310.","journal-title":"Eur Urol"},{"key":"1132_CR11","doi-asserted-by":"publisher","unstructured":"Silvani C, Santangelo A, Considine J, Tylecki A, Stephens A, Mssika A et al. Area deprivation and cancer-specific mortality in non-muscle-invasive bladder cancer: a statewide analysis. BJU Int; n\/a. https:\/\/doi.org\/10.1111\/bju.70151.","DOI":"10.1111\/bju.70151"},{"key":"1132_CR12","unstructured":"Perri A, Anna T, Vigan\u00f2 S, Bertini A, Finocchiaro A, Santangelo A et al. Socioeconomic Disparities in Prostate Cancer treatment: The Impact of Area Deprivation Index on initial treatment type for localized Prostate cancer in a North-American state-wide cohort. Urol Pract 2025; 101097UPJ0000000000000940."},{"key":"1132_CR13","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.eururo.2023.05.038","volume":"85","author":"F Preisser","year":"2024","unstructured":"Preisser F, Abrams-Pompe RS, Stelwagen PJ, B\u00f6hmer D, Zattoni F, Magli A, et al. European Association of Urology Biochemical Recurrence Risk Classification as a Decision Tool for Salvage Radiotherapy\u2014A Multicenter Study. Eur Urol. 2024;85:164\u201370.","journal-title":"Eur Urol"},{"key":"1132_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.eururo.2024.04.010","volume":"86","author":"D Tilki","year":"2024","unstructured":"Tilki D, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer. Eur Urol. 2024;86:164\u201382.","journal-title":"Eur Urol"},{"key":"1132_CR15","doi-asserted-by":"publisher","unstructured":"Bertini A, Cirulli GO, Stephens A, Finocchiaro A, Vigan\u00f2 S, Lughezzani G et al. Socioeconomic disparities in prostate cancer screening: the impact of the Area Deprivation Index on PSA screening frequency. BJU Int 2025. https:\/\/doi.org\/10.1111\/bju.16875.","DOI":"10.1111\/bju.16875"},{"key":"1132_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2025.102418","volume":"23","author":"A Bertini","year":"2025","unstructured":"Bertini A, Tylecki A, Stephens A, Finocchiaro A, Vigan\u00f2 S, Cusmano N, et al. Socioeconomic Disparities in Prostate Cancer Presentation: The Impact of ADI on Prostate Cancer Stage at Diagnosis. Clin Genitourin Cancer. 2025;23:102418.","journal-title":"Clin Genitourin Cancer"},{"key":"1132_CR17","doi-asserted-by":"publisher","first-page":"4199","DOI":"10.1002\/cncr.30834","volume":"123","author":"SJ Freedland","year":"2017","unstructured":"Freedland SJ, Vidal AC, Howard LE, Terris MK, Cooperberg MR, Amling CL, et al. Race and Risk of Metastases and Survival after Radical Prostatectomy: Results from the SEARCH Database. Cancer. 2017;123:4199\u2013206.","journal-title":"Cancer"},{"key":"1132_CR18","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.eururo.2019.03.016","volume":"75","author":"D Tilki","year":"2019","unstructured":"Tilki D, Preisser F, Graefen M, Huland H, Pompe RS. External Validation of the European Association of Urology Biochemical Recurrence Risk Groups to Predict Metastasis and Mortality After Radical Prostatectomy in a European Cohort. Eur Urol. 2019;75:896\u2013900.","journal-title":"Eur Urol"},{"key":"1132_CR19","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/JU.0000000000004118","volume":"212","author":"GO Cirulli","year":"2024","unstructured":"Cirulli GO, Davis M, Stephens A, Chiarelli G, Finati M, Corsi N, et al. Impact of Prostate-Specific Antigen Screening Pattern on Prostate Cancer Mortality Among Non-Hispanic Black and Non-Hispanic White Men: A Large, Urban Health System Cohort Analysis. J Urol. 2024;212:560\u201370.","journal-title":"J Urol"},{"key":"1132_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/pros.24803","volume":"85","author":"M Finati","year":"2025","unstructured":"Finati M, Morrison C, Stephens A, Chiarelli G, Cirulli GO, Tinsley S, et al. Association of race with incidence, characteristics, and mortality from incidental prostate cancer: Analysis of two North American contemporary cohorts. Prostate. 2025;85:82\u201389.","journal-title":"Prostate"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01132-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01132-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01132-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:00:21Z","timestamp":1790719221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01132-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1132"],"URL":"https:\/\/doi.org\/10.1038\/s41391-026-01132-5","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"24 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the relevant guidelines and regulations. Ethical approval was obtained from the Henry Ford Health Institutional Review Board (HFH-IRB#16225-01). Given the retrospective nature of the study and the use of deidentified previously collected data, a waiver of informed consent was granted by the Institutional Review Board. No identifiable patient images were used in this manuscript.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"None of the contributing authors have any conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}